CASE STUDIES: Concerns over cervical cancer vaccine in Ireland

The Department of Health says it continually monitors the HPV cervical cancer vaccine following concerns about possible adverse reactions. Some 861 cases have now been reported to the health authorities.

CASE STUDIES: Concerns over cervical cancer vaccine in Ireland

Gardasil, the vaccine manufactured by Sanofi-Pasteur, is offered to girls from the age of 12 to protect them against developing certain strains of cervical cancer.

Speculation about potential adverse reaction to the vaccine has grown internationally, and this week, the European Medicines Agency launched a review of the cervical cancer vaccine’s safety, while asserting that the review should not raise questions about whether the vaccine’s benefits in preventing cervical cancer outweigh their risks.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited